LOGICBIO THERAPEUTICS INC - COM (LOGC)

CUSIP: 54142F102

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
15,742,889
Share change
-1,875,663
Total reported value
$69,897,379
Price per share
$4.44
Number of holders
57
Value change
-$11,145,284
Number of buys
29
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 54142F102?
CUSIP 54142F102 identifies LOGC - LOGICBIO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOGICBIO THERAPEUTICS INC - COM (LOGC) as of Q2 2021

As of 30 Jun 2021, LOGICBIO THERAPEUTICS INC - COM (LOGC) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,742,889 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, SAMLYN CAPITAL, LLC, VANGUARD GROUP INC, FMR LLC, Lion Point Capital, LP, BAKER BROS. ADVISORS LP, PURA VIDA INVESTMENTS, LLC, BlackRock Inc., and Verition Fund Management LLC. This page lists 57 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.